The letter from Cantor brokerage firm really tells it all. It shows exactly how on point Unilife is nailing all these contracts with global pharmaceutical companies, how well it is positioned for the future success and profits, and how a real financial analysts view a corporation.
Very glad to see Cantor Fitzgerald back Unilife.
My confidence in Unilife Management and their slick business model has been reconfirmed.
Congrats to Alan and Team for getting this far and staying true to their commitments in the end.
UNS Price at posting:
78.0¢ Sentiment: LT Buy Disclosure: Held
